Design Therapeutics Files Q1 2026 10-Q
Ticker: DSGN · Form: 10-Q · Filed: Apr 28, 2026 · CIK: 0001807120
| Field | Detail |
|---|---|
| Company | Design Therapeutics, Inc. (DSGN) |
| Form Type | 10-Q |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Design Therapeutics filed its 10-Q for Q1 2026. Check financials.
AI Summary
Design Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2026. The filing includes financial statements and other disclosures relevant to investors. The company is located at 6005 Hidden Valley Road, Suite 110, Carlsbad, CA 92011.
Why It Matters
This filing provides investors with an update on Design Therapeutics' financial performance and operational status for the first quarter of 2026, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Numbers
- 2026-03-31 — Period End Date (Indicates the financial reporting period covered by the 10-Q.)
- 2026-04-28 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Design Therapeutics, Inc. (company) — Filer of the 10-Q
- 0001807120 (company) — CIK number for Design Therapeutics, Inc.
- 2026-04-28 (date) — Filing Date of the 10-Q
- 2026-03-31 (date) — Period of Report for the 10-Q
- 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 (company) — Mailing and Business Address for Design Therapeutics, Inc.
FAQ
What is the primary purpose of this 10-Q filing?
The primary purpose of this 10-Q filing is to provide a quarterly report on Design Therapeutics, Inc.'s financial performance and operational status for the period ending March 31, 2026.
When was this 10-Q filing accepted by the SEC?
This 10-Q filing was accepted by the SEC on 2026-04-28.
What is the CIK number for Design Therapeutics, Inc.?
The CIK number for Design Therapeutics, Inc. is 0001807120.
What is the business address of Design Therapeutics, Inc.?
The business address of Design Therapeutics, Inc. is 6005 Hidden Valley Road, Suite 110, Carlsbad, CA 92011.
What period does this 10-Q report cover?
This 10-Q report covers the period ending March 31, 2026.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 28, 2026 regarding Design Therapeutics, Inc. (DSGN).